Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,815 | 73,456 | 151,795 | 147,017 | 245,598 |
| Marketable Securities | 88,369 | 198,036 | 214,458 | 148,139 | 98,913 |
| Receivables | 58 | 7,580 | 4,945 | 333 | 5,206 |
| Other current assets | 0 | 0 | 0 | 6,100 | 0 |
| TOTAL | $156,444 | $288,859 | $379,280 | $308,426 | $355,248 |
| Non-Current Assets | |||||
| PPE Net | 7,033 | 8,496 | 10,071 | 14,526 | 19,475 |
| Other Non-Current Assets | 5,391 | 10,047 | 13,036 | 6,091 | 5,680 |
| TOTAL | $12,424 | $18,543 | $23,107 | $20,617 | $25,155 |
| Total Assets | $168,868 | $307,402 | $402,387 | $329,043 | $380,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,982 | 8,453 | 5,246 | 9,663 | 9,026 |
| Accrued Expenses | 17,099 | 33,638 | 33,258 | 29,945 | 22,991 |
| Other current liabilities | N/A | 366 | 17,774 | 2,975 | 4,872 |
| TOTAL | $20,081 | $47,842 | $61,355 | $42,583 | $39,718 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,829 |
| Other Non-Current Liabilities | 149 | 0 | 5,385 | 6,417 | 574 |
| TOTAL | $149 | $N/A | $5,385 | $6,417 | $9,966 |
| Total Liabilities | $20,230 | $47,842 | $66,740 | $49,000 | $49,684 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,462 | 82,047 | 78,049 | 76,692 | 67,753 |
| Common Shares | 83 | 82 | 78 | 71 | 67 |
| Retained earnings | -724,008 | -581,633 | -418,966 | -298,631 | -196,144 |
| Other shareholders' equity | 18 | -302 | -129 | 4 | 25 |
| TOTAL | $148,638 | $259,560 | $335,647 | $280,043 | $330,719 |
| Total Liabilities And Equity | $168,868 | $307,402 | $402,387 | $329,043 | $380,403 |